Telix Pharmaceuticals (TLX) Receivables Refunds (2023 - 2025)
Telix Pharmaceuticals (TLX) posted Receivables Refunds of $6.0 million for Q4 2025, down 2.87% on a QoQ basis from $6.2 million in Q4 2024, and down 2.87% year-over-year from $6.2 million in Q4 2024.
Telix Pharmaceuticals (TLX) has 3 years of Receivables Refunds data on file, last reported at $6.0 million in Q4 2025.
- In Q4 2025, Receivables Refunds fell 2.87% year-over-year to $6.0 million; the TTM figure through Dec 2025 stood at $6.0 million (down 2.87% YoY), while the FY2025 annual figure was $6.0 million, up 2.22% from the prior year.
- Receivables Refunds eased to $6.0 million in Q4 2025, from $6.2 million in the prior quarter.
- Across five years, Receivables Refunds topped out at $6.2 million in Q4 2024 and bottomed at $3.1 million in Q4 2023.
- A 3-year average of $5.1 million and a median of $6.0 million in 2025 frame the typical range for Receivables Refunds.
- Annual changes were most pronounced in 2024 — Receivables Refunds jumped 101.67% — and 2025, when it slipped 2.87%.
- Year by year, Receivables Refunds stood at $3.1 million in 2023, then jumped by 101.67% to $6.2 million in 2024, then decreased by 2.87% to $6.0 million in 2025.
- The last three Receivables Refunds figures came in at $6.0 million (Q4 2025), $6.2 million (Q4 2024), and $3.1 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Refund Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Telix Pharmaceuticals | 4.52 Bn | 4.38 Bn | - | 6.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.04 Mn |
| Dec 31, 2024 | 6.22 Mn |
| Dec 31, 2023 | 3.09 Mn |